Repetitive weekly cycles of interleukin-2. II. Clinical and immunologic effects of dose, schedule, and addition of indomethacin.
about
A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology GroupCharacterization of the interleukin 2 receptors (IL-2R) expressed on human natural killer cells activated in vivo by IL-2: association of the p64 IL-2R gamma chain with the IL-2R beta chain in functional intermediate-affinity IL-2R.Increased expression of the interleukin 2 (IL-2) receptor beta chain (p70) on CD56+ natural killer cells after in vivo IL-2 therapy: p70 expression does not alone predict the level of intermediate affinity IL-2 binding.Modulation of immune parameters in patients with metastatic renal-cell cancer receiving combination immunotherapy (IL-2, IFN alpha and autologous IL-2-activated lymphocytes).Prolonged interleukin-2 (IL-2) treatment can augment immune activation without enhancing antitumor activity in renal cell carcinoma.Interleukin 2.Fever and the use of paracetamol during IL-2-based immunotherapy in metastatic melanoma.Application of chemical immunomodulators to the treatment of cancer and AIDS.The induction of immune responses to murine malignant mesothelioma by IL-2 gene transfer.Malignant plasma cells are sensitive to LAK cell lysis: pre-clinical and clinical studies of interleukin 2 in the treatment of multiple myeloma.Immunomodulation during prolonged treatment with combined interleukin-2 and interferon-alpha in patients with advanced malignancy
P2860
Q33370628-9AB7AECD-DF1F-4BB1-BE0F-834ABBECBCF7Q36231652-4AD1A154-05CC-4DDC-9FE9-E167BF2010AAQ36353604-8DD8CD33-B301-433B-BAAD-B3A6A3D5B618Q36791584-F42D67D5-1502-42DD-81D6-5489F42DDDEBQ37686896-60A02AE1-FF20-444D-B6F2-7B20388AB5CCQ37808664-BF1E4C04-B154-46CF-B4D5-BF2FE6EE13EDQ40180453-325CD209-0CB5-49C3-A9B3-52209665BC48Q40651609-400E8A8E-0DB8-4CA1-A43F-7150EA72E3D5Q41095702-479B2360-F2A5-4424-842D-DD04C1E494D4Q41727048-25225C23-26FA-4DC1-A797-DCCD76D44562Q41827234-E3035FEE-543D-4795-B4D6-2194E7D49AA0
P2860
Repetitive weekly cycles of interleukin-2. II. Clinical and immunologic effects of dose, schedule, and addition of indomethacin.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
Repetitive weekly cycles of in ...... and addition of indomethacin.
@en
type
label
Repetitive weekly cycles of in ...... and addition of indomethacin.
@en
prefLabel
Repetitive weekly cycles of in ...... and addition of indomethacin.
@en
P2093
P356
P1476
Repetitive weekly cycles of in ...... and addition of indomethacin.
@en
P2093
Bechhofer R
P304
P356
10.1093/JNCI/80.18.1451
P407
P577
1988-11-01T00:00:00Z